Cullinan Therapeutics News, Cullinan Therapeutics Quote, CGEM Quote

Cullinan Therapeutics (NQ:CGEM) Delayed: 17.73 -0.22 (1.23%)

Prev. Close

$17.95

Today 6M 1Y 5Y

Open

$18.14

52 Wk High

$0.19

52 Wk Low

$0.03

Day High

$18.43

Day Low

$17.39

P/E

N/A

EPS

$0.00

Volume

361,755

Friends, Peers and Foes (?): GILD, 0QW0, ARGX, HYFT, IDXX (more...)

ALERTS | RSS

Aug 6, 2026 07:59 AM Cullinan Oncology, Inc. (CGEM) Reports In-Line Q2 EPS
Aug 6, 2026 07:00 AM Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Jul 28, 2026 07:00 AM Cullinan Therapeutics to advance CLN-049 to Phase 2 AML study
Jul 28, 2026 07:00 AM Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML
Jul 7, 2026 05:00 PM Form 4 Cullinan Therapeutics, For: Jul 06 Filed by: Michaelson Jennifer
Jul 2, 2026 05:01 PM Form 4 Cullinan Therapeutics, For: Jun 30 Filed by: SUMER JACQUELYN L
Jul 2, 2026 05:01 PM Form 4 Cullinan Therapeutics, For: Jun 30 Filed by: Fenton Mary Kay
Jun 18, 2026 05:01 PM Form 4 Cullinan Therapeutics, For: Jun 16 Filed by: Rosenberg Anthony
Jun 18, 2026 05:01 PM Form 4 Cullinan Therapeutics, For: Jun 16 Filed by: Allen Andrew R
Jun 18, 2026 05:01 PM Form 4 Cullinan Therapeutics, For: Jun 16 Filed by: Meek David D.

Entities mentioned with CGEM

View All Entities